MedTrace Logo

Purine Metabolism Enzyme SNP to Uric Acid Production

NCT01830725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-08-30

No results posted yet for this study

Summary

Determine whether a relationship exists between polymorphisms of the genes XDH, HPRT1, and PRPS1 and gout, hyperuricemia, or the dose of xanthine oxidase (XO) inhibitors to reach a goal serum uric acid of less than 6 mg/dL. This study is observational in nature as no dose adjustment of XO inhibitors will be made by study investigators.

Conditions

  • Gout
  • Hyperuricemia

Sponsors & Collaborators

  • United States Air Force

    collaborator FED

  • Keesler Air Force Base Medical Center

    lead FED

Principal Investigators

  • Matthew B Carroll, MD · Keesler Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01830725 on ClinicalTrials.gov